ZNF204P is a stemness-associated oncogenic long non-coding RNA in hepatocellular carcinoma |
Hwang, Ji-Hyun
(Interdisciplinary Program of Integrated OMICS for Biomedical Science, The Graduate School, Yonsei University)
Lee, Jungwoo (Interdisciplinary Program of Integrated OMICS for Biomedical Science, The Graduate School, Yonsei University) Choi, Won-Young (Interdisciplinary Program of Integrated OMICS for Biomedical Science, The Graduate School, Yonsei University) Kim, Min-Jung (Interdisciplinary Program of Integrated OMICS for Biomedical Science, The Graduate School, Yonsei University) Lee, Jiyeon (Severance Biomedical Science Institute, Graduate School of Medical Science, Brain Korea 21 Project, Gangnam Severance Hospital, Yonsei University College of Medicine) Chu, Khanh Hoang Bao (Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University) Kim, Lark Kyun (Severance Biomedical Science Institute, Graduate School of Medical Science, Brain Korea 21 Project, Gangnam Severance Hospital, Yonsei University College of Medicine) Kim, Young-Joon (Interdisciplinary Program of Integrated OMICS for Biomedical Science, The Graduate School, Yonsei University) |
1 | Nio K, Yamashita T, and Kaneko S (2017) The evolving concept of liver cancer stem cells. Mol Cancer 16, 4 DOI |
2 | Yang L, Shi P, Zhao G et al (2020) Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther 5, 8 DOI |
3 | Kim WT and Ryu CJ (2017) Cancer stem cell surface markers on normal stem cells. BMB Rep 50, 285-298 DOI |
4 | Chen S, Zhu J, Wang F et al (2017) LncRNAs and their role in cancer stem cells. Oncotarget 8, 110685-110692 DOI |
5 | Statello L, Guo CJ, Chen LL, and Huarte M (2021) Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 22, 96-118 DOI |
6 | Yan X, Hu Z, Feng Y et al (2015) Comprehensive genomic characterization of long non-coding RNAs across human cancers. Cancer Cell 28, 529-540 DOI |
7 | Yndestad S, Austreid E, Skaftnesmo KO, Lonning PE, and Eikesdal HP (2018) Divergent activity of the pseudogene PTENP1 in ER-positive and negative breast cancer. Mol Cancer Res 16, 78-89 DOI |
8 | Lou WY, Ding BS, and Fu PF (2020) Pseudogene-derived lncRNAs and their miRNA sponging mechanism in human Cancer. Front Cell Dev Biol 8, 85 DOI |
9 | Chiba T, Miyagi S, Saraya A et al (2008) The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma. Cancer Res 68, 7742 DOI |
10 | Zhang J, Luo N, Luo Y, Peng Z, Zhang T, and Li S (2012) microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb. Int J Oncol 40, 747-756 DOI |
11 | Jia Y, Liu H, Zhuang Q et al (2012) Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145. Oncol Rep 27, 1865-1872 DOI |
12 | Lian Q, Wang S, Zhang G et al (2018) HCCDB: a database of hepatocellular carcinoma expression atlas. Genomics Proteomics Bioinformatics 16, 269-275 (Available from: http://lifeome.net/database/hccdb/download.html) DOI |
13 | Gui X, Li H, Li T, Pu H, and Lu D (2015) Long noncoding RNA CUDR regulates HULC and β-Catenin to govern human liver stem cell malignant differentiation. Mol Ther 23, 1843-1853 DOI |
14 | Li H, An J, Wu M et al (2015) LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2. Oncotarget 6, 27847-27864 DOI |
15 | Shi J, Levinson DF, Duan J et al (2009) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460, 753-757 DOI |
16 | Morelli E, Gulla A, Amodio N et al (2021) CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) to explore the oncogenic lncRNA network. Methods Mol Biol 2348, 189-204 DOI |
17 | Hon C-C, Ramilowski JA, Harshbarger J et al (2017) An atlas of human long non-coding RNAs with accurate 5' ends. Nature 543, 199-204 DOI |
18 | Lamb JR, Zhang C, Xie T et al (2011) Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting. PLoS One 6, e20090 DOI |
19 | Qin XY, Suzuki H, Honda M et al (2018) Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid. Proc Natl Acad Sci U S A 115, 4969-4974 DOI |
20 | Takahashi K, Tanabe K, Ohnuki M et al (2014) Induction of pluripotency in human somatic cells via a transient state resembling primitive streak-like mesendoderm. Nat Commun 5, 3678 DOI |
21 | Chandrashekar DS, Bashel B, Balasubramanya SAH et al (2017) UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia (New York, N.Y.) 19, 649-658 DOI |
22 | Lu TP, Lee CY, Tsai MH et al (2012) miRSystem: an integrated system for characterizing enriched functions and pathways of microRNA targets. PLoS One 7, e42390 DOI |
23 | Zou S, Wang C, Liu J et al (2017) Sox12 is a cancer stem-like cell marker in hepatocellular carcinoma. Mol Cells 40, 847-854 DOI |
24 | Xie Z, Bailey A, Kuleshov MV et al (2021) Gene set knowledge discovery with enrichr. Curr Protoc 1, e90 |
25 | Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, and Tamayo P (2015) The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst 1, 417-425 DOI |
26 | Labun K, Montague TG, Krause M, Torres Cleuren YN, Tjeldnes H, and Valen E (2019) CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing. Nucleic Acids Res 47, W171-W174 DOI |
27 | Zhang H and Wang ZZ (2008) Mechanisms that mediate stem cell self-renewal and differentiation. J Cell Biochem 103, 709-718 DOI |
28 | Shi G and Jin Y (2010) Role of Oct4 in maintaining and regaining stem cell pluripotency. Stem Cell Res Ther 1, 39 DOI |
29 | European Association for the Study of the Liver (2018) EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 69, 182-236 DOI |
30 | Ginestier C, Hur MH, Charafe-Jauffret E et al (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555-567 DOI |
31 | Fatica A and Bozzoni I (2014) Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet 15, 7-21 DOI |
32 | Xu Y, Yu X, Wei C, Nie F, Huang M, and Sun M (2018) Over-expression of oncigenic pesudogene DUXAP10 promotes cell proliferation and invasion by regulating LATS1 and β-catenin in gastric cancer. J Exp Clin Cancer Res 37, 13 DOI |
33 | Tsui YM, Chan LK, and Ng IOL (2020) Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential. Br J Cancer 122, 1428-1440 DOI |
34 | Xu N, Papagiannakopoulos T, Pan G, Thomson JA, and Kosik KS (2009) MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137, 647-658 DOI |
35 | Lin H, Qiu X, Zhang B, and Zhang J (2018) Identification of the predictive genes for the response of colorectal cancer patients to FOLFOX therapy. OncoTargets Ther 11, 5943-5955 DOI |
![]() |